BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3990443)

  • 81. A study on structure-activity relationships of nucleoside analogues.
    Beránek J
    Drugs Exp Clin Res; 1986; 12(4):355-67. PubMed ID: 3013563
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Mechanism of action of 2',5-difluoro-1-arabinosyluracil.
    Coderre JA; Santi DV; Matsuda A; Watanabe KA; Fox JJ
    J Med Chem; 1983 Aug; 26(8):1149-52. PubMed ID: 6876083
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The antiproliferative activity of DMDC is modulated by inhibition of cytidine deaminase.
    Eda H; Ura M; F-Ouchi K; Tanaka Y; Miwa M; Ishitsuka H
    Cancer Res; 1998 Mar; 58(6):1165-9. PubMed ID: 9515801
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Structure-activity analysis of antagonism of the feedback inhibition of thymidine kinase.
    Fischer PH; Fang TT; Lin TS; Hampton A; Bruggink J
    Biochem Pharmacol; 1988 Apr; 37(7):1293-8. PubMed ID: 3355601
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The molecular targets of antitumor 2'-deoxycytidine analogues.
    Obata T; Endo Y; Murata D; Sakamoto K; Sasaki T
    Curr Drug Targets; 2003 May; 4(4):305-13. PubMed ID: 12699351
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Phosphorolysis of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and other 5-substituted-2'-deoxyuridines by purified human thymidine phosphorylase and intact blood platelets.
    Desgranges C; Razaka G; Rabaud M; Bricaud H; Balzarini J; De Clercq E
    Biochem Pharmacol; 1983 Dec; 32(23):3583-90. PubMed ID: 6651877
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Antileukemic effects of pseudoisocytidine, a new synthetic pyrimidine C-nucleoside.
    Burchenal JH; Ciovacco K; Kalaher K; O'Toole T; Kiefner R; Dowling MD; Chu CK; Watanabe KA; Wempen I; Fox JJ
    Cancer Res; 1976 Apr; 36(4):1520-3. PubMed ID: 1260769
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Detection of deoxyribonucleoside-triphosphate imbalance death-induced DNA double strand breakage in FM3A cells by orthogonal-field-alternation gel electrophoresis (OFAGE).
    Wataya Y; Hazawa T; Watanabe K; Hirota Y; Yoshioka-Hiramoto A
    Nucleic Acids Symp Ser; 1988; (19):53-5. PubMed ID: 2976158
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of deoxycytidine on the in vitro response of human leukemia cells to inhibitors of de novo pyrimidine biosynthesis.
    Bhalla K; Grant S
    Cancer Chemother Pharmacol; 1987; 19(3):226-32. PubMed ID: 3581416
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase.
    De Clercq E; Murase J; Marquez VE
    Biochem Pharmacol; 1991 Jun; 41(12):1821-9. PubMed ID: 1710119
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine.
    Bijnsdorp IV; Schwendener RA; Schott H; Fichtner I; Smid K; Laan AC; Schott S; Losekoot N; Honeywell RJ; Peters GJ
    Invest New Drugs; 2011 Apr; 29(2):248-57. PubMed ID: 19957099
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides.
    Munch-Petersen B; Cloos L; Tyrsted G; Eriksson S
    J Biol Chem; 1991 May; 266(14):9032-8. PubMed ID: 2026611
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Effects of Chinese herbal medicines on DNA-synthesizing enzyme activities in mammary tumors of mice.
    Sakamoto S; Furuichi R; Matsuda M; Kudo H; Suzuki S; Sugiura Y; Kuwa K; Tajima M; Matsubara M; Namiki H
    Am J Chin Med; 1994; 22(1):43-50. PubMed ID: 8030618
    [TBL] [Abstract][Full Text] [Related]  

  • 94. 5-fluorodeoxyuridine decreases the effect of arabinofuranosyl-cytosine in undifferentiated human B lymphocytes.
    Spasokukotskaja T; Taljanidisz J; Benczur M; Staub M
    Acta Biochim Biophys Hung; 1988; 23(2):159-73. PubMed ID: 2976562
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Biotransformation and in vitro activity of an arabinosylcytosine 5'-chloro-5'-deoxy analog.
    Novotný L; Reichelová V; Balázová E; Scheithauer W; Benesová M; Ujházy V
    Anticancer Drugs; 1991 Oct; 2(5):495-502. PubMed ID: 1804392
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Rational design of selective antimetabolites of DNA-thymine biosynthesis: 5-propynylpyrimidine nucleoside derivatives.
    Kalman TI; Nie Z
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):357-69. PubMed ID: 10772720
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Biological effects of 5-carboxy-2'-deoxyuridine: hydrolysis product of 5-trifluoromethyl-2'-deoxyuridine.
    Clough DW; Wigdahl BL; Parkhurst JR
    Antimicrob Agents Chemother; 1978 Jul; 14(1):126-31. PubMed ID: 28691
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Mechanism of action of 5-nitro-2'-deoxyuridine.
    Washtien WL; Santi DV
    J Med Chem; 1982 Oct; 25(10):1252-5. PubMed ID: 6183429
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Isolation of mouse FM3A cell mutants with thermolabile thymidylate synthetase by resistance to aphidicolin.
    Ayusawa D; Iwata K; Seno T
    Biochem Biophys Res Commun; 1980 Oct; 96(4):1654-61. PubMed ID: 6778479
    [No Abstract]   [Full Text] [Related]  

  • 100. Antitumor activity of sugar-modified cytosine nucleosides.
    Matsuda A; Sasaki T
    Cancer Sci; 2004 Feb; 95(2):105-11. PubMed ID: 14965358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.